These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25881775)

  • 21. Delayed Intravenous Thrombolysis in Patients with Minor Stroke.
    Yoo J; Sohn SI; Kim J; Ahn SH; Lee K; Baek JH; Kim K; Hong JH; Koo J; Kim YD; Kwak J; Nam HS; Heo JH
    Cerebrovasc Dis; 2018; 46(1-2):52-58. PubMed ID: 30092583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing door-to-puncture times for intra-arterial stroke therapy: a pilot quality improvement project.
    Mehta BP; Leslie-Mazwi TM; Chandra RV; Bell DL; Sun CH; Hirsch JA; Rabinov JD; Rost NS; Schwamm LH; Goldstein JN; Levine WC; Gupta R; Yoo AJ
    J Am Heart Assoc; 2014 Nov; 3(6):e000963. PubMed ID: 25389281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
    Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke.
    Xian Y; Smith EE; Zhao X; Peterson ED; Olson DM; Hernandez AF; Bhatt DL; Saver JL; Schwamm LH; Fonarow GC
    Stroke; 2014 May; 45(5):1387-95. PubMed ID: 24713527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Emergency Medical Services and Timely Treatment Among Ischemic Stroke.
    Gu HQ; Rao ZZ; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Wang CY; Liu C; Li H; Li ZX; Xiao RP; Wang YJ;
    Stroke; 2019 Apr; 50(4):1013-1016. PubMed ID: 30841820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why are acute ischemic stroke patients not receiving IV tPA? Results from a national registry.
    Messé SR; Khatri P; Reeves MJ; Smith EE; Saver JL; Bhatt DL; Grau-Sepulveda MV; Cox M; Peterson ED; Fonarow GC; Schwamm LH
    Neurology; 2016 Oct; 87(15):1565-1574. PubMed ID: 27629092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
    Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
    J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes.
    Fonarow GC; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Grau-Sepulveda MV; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
    Circulation; 2011 Feb; 123(7):750-8. PubMed ID: 21311083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Door to Intravenous Tissue Plasminogen Activator Time and Hospital Length of Stay in Acute Ischemic Stroke Patients, Georgia, 2007-2013.
    Ido MS; Okosun IS; Bayakly R; Clarkson L; Lugtu J; Floyd S; Krompf K; Frankel M
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):866-71. PubMed ID: 26853143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of tissue-type plasminogen activator before and after publication of the European Cooperative Acute Stroke Study III in Get With The Guidelines-Stroke.
    Messé SR; Fonarow GC; Smith EE; Kaltenbach L; Olson DM; Kasner SE; Schwamm LH
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):321-6. PubMed ID: 22550132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.
    Minnerup J; Wersching H; Ringelstein EB; Schilling M; Schäbitz WR; Wellmann J; Berger K
    Stroke; 2011 Oct; 42(10):2838-43. PubMed ID: 21852612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterior circulation stroke is associated with prolonged door-to-needle time.
    Sarraj A; Medrek S; Albright K; Martin-Schild S; Bibars W; Vahidy F; Grotta JC; Savitz SI
    Int J Stroke; 2015 Jul; 10(5):672-8. PubMed ID: 23521891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME; Nunziato EC; Labovitz DL
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):808-11. PubMed ID: 21640608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR).
    Wang Y; Liao X; Zhao X; Wang DZ; Wang C; Nguyen-Huynh MN; Zhou Y; Liu L; Wang X; Liu G; Li H; Wang Y;
    Stroke; 2011 Jun; 42(6):1658-64. PubMed ID: 21512182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Older Stroke Patients with High Stroke Scores Have Delayed Door-To-Needle Times.
    Birnbaum LA; Rodriguez JS; Topel CH; Behrouz R; Misra V; Palacio S; Patterson MG; Motz DS; Goros MW; Cornell JE; Caron JR
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2668-2672. PubMed ID: 27476342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke.
    Kamal N; Sheng S; Xian Y; Matsouaka R; Hill MD; Bhatt DL; Saver JL; Reeves MJ; Fonarow GC; Schwamm LH; Smith EE
    Stroke; 2017 Apr; 48(4):946-954. PubMed ID: 28228574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Administration of tissue plasminogen activator for acute ischemic stroke in a rural Wisconsin hospital.
    Charipar R; Charipar E
    WMJ; 2008 Jul; 107(4):176-80. PubMed ID: 18702433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.